Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Ackeifi C, Swartz E, Kumar K et al
CARDIORENAL BENEFITS OF SGLT2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS FROM RENAL AND CARDIOVASCULAR OUTCOME TRIALS Among large-scale clinical trials involving SGLT2 inhibitors and GLP-1RA, there exists only one dedicated renal outcome trial that has been published to date
Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol
Chen TH, et al
Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes
US$ 28.03
US$ 27.27
US$ 28.13
US$ 28.94
